TABLE 2.
Toxicity researches of BBR.
| Animals/cell lines | Dose | Administration method | Duration | Detail | Ref. |
|---|---|---|---|---|---|
| Fourth instar larvae | 10 mg/L BBR plus near UVA | — | 24 h | Decreased larval survival | Philogène et al. (1984) |
| Wistar and Sprague-Dawley rats | 2, 10, 20 μg/g | intraperitoneal injection | 7 days | Higher mean serum bilirubin concentration | Chan (1993) |
| Balb/c mice | 10 mg/kg | intraperitoneal injection | 14 days | Cellular and humoral immune functions suppression | Mahmoudi et al. (2016) |
| 5 mg/kg | Delayed-type hypersensitivity responses, lymphoproliferation | ||||
| Zebrafish embryos | 100 mg/L | — | 24–96 h | Teratogenic effect, developmental toxicity, pericardial edema, cardiac looping defects, late heart morphogenesis impairment, early cardiac functionality impairment | Martini et al. (2020) |
| Cerebellar granule neurons, hippocampal neurons | 0.01–10 µM | 0.5–24 h | Severe disruption of neuritic and nuclear integrity, functional and morphological alterations of neuronal mitochondria | Kysenius et al. (2014) | |
| Sprague-Dawley rat cardiomyocytes | 10 μM | — | 24 h | Cardiac arrest, total beating rate and amplitude inhibition | Zhang et al. (2018) |
Note- :no relevant data.